PATIENTS with type 2 diabetes and obstructive sleep apnea experienced significantly greater survival benefits from GLP-1 receptor agonist therapy than those without sleep apnea, according to a large-scale analysis of nearly 1.8 million medical…
GLP-1 Therapy Improves Survival in Diabetes and Sleep Apnea – European Medical Journal GLP-1 Therapy Improves Survival in Diabetes and Sleep Apnea
